Pelvic and Paraortic Lymph Node Response to Chemoradiation Therapy in Patients With Locally Advanced Cervical Cancer: Does a Higher Boost Dose Impact Nodal Control?

HR-CTV D90 -5.0 8 -3.0 6 -1.7 4 -0.9 2 0.4 2 1.0 5 1.2 8 1.4 13 HR-CTV D100 -6.2 11 -3.9 8 -2.4 5 -1.0 2 1.0 3 2.3 4 3.2 8 3.8 14 Rectum D2cc 37.1 5 22.5 3 12.9 2 6.3 1 -5.1 1 -9.8 2 -15.3 4 -21.4 6 Bladder D2cc -11.0 5 -7.5 3 -4.9 2 -2.6 1 2.5 1 5.4 2 9.6 4 15.4 6 Sigmoid D2cc -6.7 7 -4.1 5 -2.5 3 -1.2 1 0.7 1 1.5 2 2.4 4 3.2 6 Point A Left -5.5 9 -3.2 6 -1.8 4 -0.8 2 0.7 2 1.2 5 1.9 8 2.8 12 Point A Right -7.0 11 -4.5 8 -2.8 5 -1.5 3 1.1 3 2.7 6 4.7 11 7.5 19 ICRU Rectum 23.7 27 14.9 16 8.7 9 4.3 4 -4.1 3 -8.2 6 -13.5 9 -20.0 12 ICRU Bladder -4.2 10 -2.6 7 -1.6 5 -0.7 2 0.7 2 1.6 5 2.5 9 3.9 15 Volume 84 Number 3S Supplement 2012 Poster Viewing Abstracts S435